Novo Nordisk A/S
ApoC-II Mimetic Peptides
Last updated:
Abstract:
The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
Status:
Application
Type:
Utility
Filling date:
9 Mar 2021
Issue date:
21 Oct 2021